NCT04431960View on ClinicalTrials.gov

Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis and CVD Risk

PHASE1CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

July 20, 2021

Primary Completion Date

October 3, 2022

Study Completion Date

October 3, 2022

Conditions
Postmenopausal OsteoporosisGut MicrobiotaCardiovascular Diseases
Interventions
DRUG

blackcurrant (BC) extract

A calcium citrate caplet (Bayer AG, Germany) will be taken by all 3 groups to avoid bone deterioration related to calcium and vitamin D deficiency

Trial Locations (1)

06269

University of Connecticut Department of Nutritional Sciences and Kinesiology Human Performance Laboratory, Storrs

All Listed Sponsors
lead

University of Connecticut

OTHER

NCT04431960 - Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis and CVD Risk | Biotech Hunter | Biotech Hunter